UAE Space Agency completes CDR for Emirates Mission to the Asteroid Belt
His Excellency Salem Butti Salem Al Qubaisi, Director General of the UAE Space Agency, said: 'We are truly proud of this achievement. Completing this phase of EMA successfully embodies the UAEs vision of turning ambitions into realities.'
Al Qubaisi added: 'The mission represents an advanced step in our journey of scientific innovation. It contributes to bolstering our position in deep space exploration, and opens promising horizons in the fields of technology, education, and economy for future generations.' He also emphasized the importance of building capabilities in scientific and technical fields within this vital sector.
The critical design review comprises a comprehensive evaluation of all aspects of the programme, from detailed designs of the spacecraft and its subsystems to precise engineering drawings, manufacturing, assembly, integration and test plans. It also includes an analysis of the expected performance to ensure that the strategic objectives of the mission are achieved, comprehensive test plans to ensure that components are ready to operate in the harsh environments of space, assessment of potential risks and the development of effective strategies to manage them. It also includes the review of the mission schedule.
Mohsen Al Awadhi, Mission Director – EMA, stressed that the mission primarily focuses on building capabilities and ensuring broad participation of the private sector. He further emphasized that the Emirates Mission to the Asteroid Belt is more than a journey beyond our planet, it is a bold step toward a future of innovation, scientific excellence, and global leadership in deep space exploration programs.
He highlighted that the critical design review is crucial to ensure the success of any space program, during which the focus is on verifying the readiness of the systems, achieving the desired scientific goals, enhancing coordination between different teams, reducing potential risks, and complying with international standards and regulations. He affirmed that this review yielded positive results and successfully achieved its objectives, reflecting remarkable progress in the National Teams capabilities, and reinforcing the preparations for the mission launch.
EMA consists of a six-year spacecraft design and development phase followed by launch and a seven-year mission to the main asteroid belt beyond Mars, performing a series of close flybys to make a series of observations of seven main belt asteroids, and finally landing on Justitia. The MBR Explorer will carry advanced scientific devices that will work together to achieve the missions scientific objectives. The mission's objectives focus on understanding the origins and evolution of water-rich asteroids and evaluating the possibility of using asteroids as resources for future space exploration missions.
The mission will measure the surface composition, geology, interior density, temperatures, and thermophysical properties of multiple asteroids in the main asteroid belt to analyse their surface evolution and history.
A group of academic partners and hardware development partners are participating in the mission, including: Khalifa University, New York University Abu Dhabi (NYUAD), the Technology Innovation Institute (TII), in addition to local and international partners from the private sector, and local and international organisations, institutions, and universities such as the Italian Space Agency, the University of Colorado Boulder, the University of Arizona, and Northern Arizona University.
The UAE Space Agency conducted a preliminary design review for the mission in February 2024 and completed the lander mission concept review in July 2024. The lander will be aboard the MBR Explorer and is designed to land on and study Justitia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
2 days ago
- Web Release
Oxford – Sheikh Mohammed bin Rashid Al Maktoum Scholarship continues to support education and innovation
The Oxford – Sheikh Mohammed bin Rashid Al Maktoum Graduate Scholarship, launched in collaboration between the Mohammed bin Rashid Al Maktoum Knowledge Foundation (MBRF) and the University of Oxford in 2016, has achieved remarkable results by supporting UAE and Arab students to pursue advanced academic studies at the University of Oxford, one of the world's most renowned universities. This collaboration exemplifies a pioneering initiative to invest in knowledge and human capital by providing Arab students with seamless access to postgraduate courses. It helps them improve their intellectual capacity by learning under the guidance of globally acclaimed academics while building robust connections with exceptional peers from different countries and diverse fields. His Excellency Jamal bin Huwaireb, CEO of MBRF, said: 'This scholarship reflects the visionary principles of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, which aim to ensure a sustainable and prosperous future. The innovative initiative seeks to empower Emirati and Arab students by offering higher education that facilitates their knowledge-based skill development. Additionally, it highlights our commitment to reinforcing scientific, academic, and research excellence in the Arab world, in line with our mission to support students and researchers locally and regionally, further positioning the UAE as a leading global knowledge hub.' The scholarship also aims to nurture exceptional students by enabling them to pursue postgraduate courses at the University of Oxford and supporting their academic and research activities. Furthermore, it contributes to the development of a robust Arab knowledge society, in line with the UAE's commitment to positioning education and innovation as key pillars for creating a prosperous future. Since its inception, the Oxford – Sheikh Mohammed bin Rashid Al Maktoum Graduate Scholarship has played a pivotal role in developing the Arab higher education system and supporting exceptional students in gaining access to the world's leading university for postgraduate study. The scholarship has become influential in global knowledge settings by enabling dozens of Arab scholars to strengthen their research and scientific expertise across various critical disciplines. Moreover, the scholarship serves as a testament to MBRF's dedication to enhancing sustainable education and providing more opportunities for Arab youth. Building on the belief that strong educational and scientific research programs are essential for progress, the scholarship continues to shape the region's future by cultivating progressive, knowledge-driven societies.
Dubai Eye
3 days ago
- Dubai Eye
Abu Dhabi launches newborn genetic testing programme
Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, including metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE nationals and children of Emirati mothers born in the emirate. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. 'Through early detection, personalised care and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare," said Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi. To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.
TAG 91.1
3 days ago
- TAG 91.1
Abu Dhabi launches newborn genetic testing programme
Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns in the world. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision medicine. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene therapy. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before." Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.' To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. Early detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.
